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Abstract
Background/objectives The impact of maternal macronutrient intake during pregnancy on offspring childhood adiposity is
unclear. We assessed the associations between maternal macronutrient intake during and after pregnancy with offspring
adiposity at 5 years of age. Additionally, we investigated whether gestational diabetes (GDM), BMI, or breastfeeding
modified these associations.
Subjects/methods Altogether, 301 mother–child dyads with maternal prepregnancy BMI ≥ 30 and/or previous GDM par-
ticipated in the Finnish Gestational Diabetes Prevention Study (RADIEL) and its 5 years follow-up. Macronutrient intakes
(E%) were calculated from 3-day food records collected at 5–18 weeks’ gestation, in the third trimester, and at 12 months
and 5 years after pregnancy. Offspring body fat mass (BFM) and fat percentage (BF%) at 5 years were measured by
bioimpedance. Statistical analyses were multivariate linear regression.
Results Mean (SD) prepregnancy BMI was 33(4) kg/m2. GDM was diagnosed in 47%. In normoglycemic women, higher
first half of pregnancy n-3 PUFA intake was associated with lower offspring BFM (g) (ß −0.90; 95% CI −1.62, −0.18) and
BF% (ß −3.45; 95% CI −6.17, −0.72). In women with GDM, higher first half of pregnancy n-3 PUFA intake was
associated with higher offspring BFM (ß 0.94; 95% CI 0.14, 1.75) and BF% (ß 3.21; 95% CI 0.43, 5.99). Higher SFA intake
in the third trimester and cumulative intake across pregnancy (mean of the first half and late pregnancy) was associated with
higher BFM and BF% (across pregnancy: ß 0.12; 95% CI 0.03, 0.20 and ß 0.44; 95% CI 0.15, 0.73, respectively). Higher
carbohydrate intake across pregnancy was associated with lower BFM (ß −0.044; 95% CI −0.086, −0.003), and borderline
associated with BF% (ß −0.15; 95% CI −0.31, 0.00).
Conclusions The macronutrient composition of maternal diet during pregnancy is associated with offspring BFM and BF%
at 5 years. GDM modifies the association between prenatal n-3 PUFA intake and offspring anthropometrics.
Introduction
Obesity is rapidly increasing in children and adolescents
worldwide. In 2019, 38 million children younger than 5
years were overweight or obese [1]. In accordance with
* Jelena Meinilä
jelena.meinila@helsinki.fi
1 Department of Food and Nutrition, University of Helsinki,
Helsinki, Finland
2 Department of Obstetrics and Gynecology, University of Helsinki
and Helsinki University Hospital, Helsinki, Finland
3 Department of Obstetrics and Gynecology, South Karelia Central
Hospital, Lappeenranta, Finland
4 Department of Medical and Clinical Genetics, University of
Helsinki and Helsinki University Hospital, Helsinki, Finland
5 Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital,
Toronto, ON, Canada
6 Folkhälsan Research Center, Helsinki, Finland
7 Faculty of Medicine, University of Helsinki, Helsinki, Finland
8 Children’s Hospital, Pediatric Research Center, University of
Helsinki and Helsinki University Hospital, Helsinki, Finland
Supplementary information The online version contains
















global trends, over 25% of Finnish preschool-aged boys and
over 15% of girls are currently overweight or obese [2].
Child obesity is associated with reduced quality of life in
childhood [3], cardiometabolic morbidity in later life [4],
and premature death [5]. Therefore, identification and tar-
geting of modifiable risk factors for childhood obesity
should be a public health priority.
Mounting evidence indicates that maternal health beha-
viors such as physical activity, smoking, and diet during
pregnancy are associated with long-term health outcomes in
the offspring [6–8]. Data from animal and human studies
suggest that, in addition to maternal gestational diabetes
(GDM) and obesity [9–11], in utero exposure to poor
quality diet (e.g., under- or over-nutrition) predisposes the
offspring to excess adiposity [12, 13]. Recent findings also
suggest that the macronutrient composition of maternal diet
during pregnancy is associated with indicators of newborn
adiposity (body mass index (BMI), waist circumference,
body fat mass (BFM), and body fat percentage (BF%))
[8, 14, 15]. However, only a few studies have examined the
associations between maternal macronutrient intake and
offspring adiposity at later ages, and analyses extending
beyond maternal polyunsaturated fatty acid (PUFA) intake
are particularly scarce [8, 16–19]. Some of the available
studies have relied only on indirect measures of adiposity,
such as weight [16] or BMI [17, 19]. Furthermore, only one
study has attempted to differentiate between the effects of
maternal nutrient intake during pregnancy and the child’s
own nutrient intake in early childhood by analyzing
maternal macronutrient intake after pregnancy as an indi-
cator of the food environment of the offspring [16]. None of
the existing studies have taken into account the child’s own
macronutrient intake. Moreover, whether the impact of
maternal macronutrient intake on the offspring body com-
position varies across gestation remains unclear.
The aim of this study was to examine the associations
between the macronutrient composition of maternal diet
during the first half of and late pregnancy and offspring
anthropometric indicators at 5 years of age (age- and sex-
adjusted BMI (ISO-BMI), waist-to-height ratio (WHtR),
BFM, and BF%). To ensure that none of the observed
associations between macronutrient intakes during preg-
nancy and offspring anthropometric indicators result from
confounding by the child’s own food environment during
childhood, we also studied the associations between
maternal macronutrient intakes at 12 months and 5 years
after pregnancy and offspring adiposity.
Subjects and methods
All background and pregnancy data were originally col-
lected during the RADIEL study, a multi-center randomized
controlled intervention trial aimed at prevention of GDM
with diet and physical activity counseling [20]. The trial
involved a total of 787 women at high risk for GDM who
delivered in the Helsinki metropolitan area or in Lappeen-
ranta, Finland, during 2008–2011. The recruited women
were obese (BMI ≥ 30 kg/m2) and/or had been diagnosed
with GDM in a previous pregnancy. At enrollment, the
women were either ≤20 weeks pregnant or planning preg-
nancy. Exclusion criteria were age <18 years, preexisting
type 1 or 2 diabetes mellitus, physical disability, multiple
pregnancy, severe psychiatric disorders, current substance
abuse, substantial communication difficulties and using
medication affecting glucose metabolism (e.g., corticoster-
oids, metformin, antidepressants with potential effects on
glucose homeostasis).
Five years after the trial, during 2013–2017, the parti-
cipants and their offspring were invited for follow-up
examinations. The study population for the present
study was formed as depicted in Fig. 1. The number of
mother–child pairs who participated in the follow-up was
332; 301 provided both a completed maternal 3-day food
record at least once during pregnancy (in the first half of
pregnancy 5–18 weeks’ gestation or in the third trimester)
and the offspring’s weight and height at 5 years. At least
one maternal food record and the offspring’s BFM and BF
% measurements at 5 years of age were available from 274
pairs. Maternal 3-day food records from both the first half
of pregnancy and third trimester of pregnancy and off-
spring’s weight and height at 5 years of age were available
from 230 mother–child pairs, with offspring BFM and
BF% at 5 years additionally available from 201 of these
pairs. In the present study, the intervention and control
groups were combined and treated as a cohort and obser-
vational analyses were performed. The study was con-
ducted according to the guidelines laid down in the
Helsinki Declaration of 1975 as revised in 1983. All pro-
cedures involving human subjects were approved by the
Ethics Committee of the Department of Obstetrics and
Gynecology of Helsinki and Uusimaa Hospital District.
Written informed consent was obtained from all subjects in
the main trial and in the 5-year follow-up. In the follow-up
study, informed consent on behalf of the child was
obtained from the parents.
Nutrient intake of the mother and child
Maternal macronutrient intake during pregnancy was cal-
culated from two 3-day food records collected in the first
half of pregnancy (gestational weeks 5–18, mean 13 ± 2)
and in the third trimester of pregnancy (mean gestational
weeks 35 ± 1), as well as at 12 months and 5 years after
delivery. At the initial trial enrollment visit in the first
half of pregnancy, mothers received written instructions
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for completing food records on three consecutive days
(two weekdays and a weekend day) immediately or as soon
as possible after each meal. They were asked to report food
and beverage labels and brand names as accurately as
possible, and record amounts as household measures (e.g.,
tablespoon, plate, scoop) or in weight units, if available.
Identical instructions were given for completing 3-day food
records in the third trimester of pregnancy and at 12 months
and 5 years after delivery.
Similarly, the offspring’s macronutrient intake at 5 years
of age was calculated from 3-day food records completed
by their caretaker (usually mother or father) with similar
accuracy as instructed for maternal food records. If the
3-day recording period included daycare time, the childcare
providers were asked to complete a separate food record
with identical instructions. Recipes and ingredients used in
daycare meals were collected from the food suppliers or the
daycare kitchen.
Trained nutritionists processed and entered the food
record data into a nutritional calculation software, AivoDiet
(versions 2.0.1.5 and 2.2.0.1, Aivo Finland Oy, Turku,
Finland). A table of usual portion sizes helped in converting
household measures and volumes into grams [21]. The food
composition database was provided by the Finnish National
Institute for Health and Welfare (www.fineli.fi). The nutri-
ent values in the database rely mostly on Finnish studies, in
addition to data obtained from Finnish food industries and
international food composition tables. The database
includes standard recipes that are based on contemporary
Finnish cookbooks. If a food or recipe reported in the food
record was missing, a new recipe was created based on the
food record.
Collection of maternal background information
At the initial trial enrollment and 5-year follow-up visits,
the mothers completed a background questionnaire on
socio-demographic factors, earlier pregnancies and deliv-
eries, and health-related behaviors during the preceding
6 months. Information on GDM was based on medical
records and physician confirmation, except for two parti-
cipants for whom this was unavailable. Prepregnancy BMI
was calculated from weight and height measured at the
first study visit (in those recruited before pregnancy) or
was self-reported (in those recruited in the first half of
pregnancy). Duration of breastfeeding (<4 months/
≥4 months) was collected from the records of the child
health centres which monitored the children’s health,
growth, and development.
Collection of offspring background data and
anthropometric measurements
Data on offspring sex, birthweight, and gestational age at
birth were collected from hospital records. Relative birth-
weight was calculated using Finnish fetal growth curves
adjusted for sex and gestational age [22]. Measurements
from the child participants were taken in the research cen-
ters of the Hospital District of Helsinki and Uusimaa or in
South Karelia Central Hospital by trained study nurses.
Height was measured with feet shoeless, flat, together, and
against the wall. Weight was measured with a digital scale
in light clothing. Waist circumference was measured at
midway between the lowest ribs and the iliac crest. Mea-
sures of height, weight, and waist were rounded to one
decimal. Offspring BFM and BF% at 5 years were mea-
sured during the 5-year visit using Bioelectrical Impedance
Analysis (InBody 720 eight-polar tactile electrode system
(Biospace Co., Ltd, Seoul, South Korea)). Offspring sex-
specific BMI-for-age at 5 years was calculated according to
the Finnish growth curves and was converted to adult scale
Fig. 1 Formation of the study population. The first half of preg-
nancy contains gestational weeks from 5 to 18. ISO-BMI represents
age- and sex-standardized BMI converted to adult scale and was cal-
culated according to Saari et al. [23].
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(ISO-BMI) according to Saari et al. [23]. Offspring WHtR
was calculated as waist circumference (cm) divided by
height (m).
Statistical methods
Descriptive characteristics are presented as means (SD) or
frequencies (%). Macronutrient intakes in the first half of
pregnancy and in the third trimester of pregnancy were
analyzed both separately and combined (mean of the
two measures) to represent cumulative intake across
pregnancy. Associations between maternal macronutrient
intakes and offspring z-birthweight, and ISO-BMI, WHtR,
BFM, and BF% at 5 years were analyzed by linear
regression analysis. Model 1 included mother’s energy
intake as a covariate. Model 2 additionally included
potential confounding factors such as maternal age during
pregnancy, educational attainment (years), smoking in the
first half of pregnancy (yes/no), GDM status (yes/no),
intervention allocation (control/intervention during the
main trial), maternal prepregnancy BMI, offspring sex,
offspring age at 5-year follow-up visit, offspring’s z-
birthweight, and offspring’s intake of the given nutrient
(E%) at 5 years of age. Additionally, we constructed a
model without the variables that could potentially be
involved in the causal pathways between maternal mac-
ronutrient intake and offspring anthropometric measures:
GDM status, intervention allocation, maternal pre-
pregnancy BMI, offspring z-birthweight, and offspring’s
intake of the index nutrient at 5 years of age. The results
of this additional model are not presented since they did
not differ substantially from those obtained with Model 2.
Information on maternal leisure-time physical activity
(LTPA) and duration of breastfeeding, potential con-
founders in the association between maternal diet and
offspring anthropometric indicators, were missing from
several participants (LTPA: 34 mothers with only first half
of pregnancy food records, 17 mothers with only third
trimester food records, and 42 mothers with two food
records during pregnancy; breastfeeding: 28 mothers with
only first half of pregnancy food records, 7 mothers with
only third trimester food records, and 23 mothers with two
food records during pregnancy). Therefore, these vari-
ables were omitted from the main analyses. However, in
sensitivity analyses, LTPA and duration of breastfeeding
were added separately as covariates, in addition to the
variables of Model 2. We also tested nutrient interaction
with variables GDM, duration of breastfeeding, and pre-
pregnancy BMI on offspring anthropometric indicators.
Each interaction was tested in a separate analysis by
including in the models both the interaction term
([GDM × nutrient intake (E%)]/[duration of breastfeed-
ing × nutrient intake (E%)]/[prepregnancy BMI × nutrient
intake (E%)]) and its components as independent vari-
ables, together with the other covariates of Model 2. This
was performed for all studied nutrients in all timepoints
(first half of pregnancy, third trimester, and 12 months
and 5 years after pregnancy). If an interaction was found,
the analyses were performed in subgroups according to
the variable with which the interaction was identified.
If an association between maternal intake of a macro-
nutrient and offspring ISO-BMI, WHtR, BFM, or BF% was
found, additional analyses were performed to assess whe-
ther the observed association was due to intake during
pregnancy or due to maintained nutrient intake after preg-
nancy (which could reflect the food environment of the
offspring). The nutrient intakes of Model 2 were replaced
with maternal intakes at 12 months or 5 years after delivery,
and the offspring’s own intakes of specific nutrients were
excluded from the model.
We also tested quadratic associations between macro-
nutrients and BFM and BF% by adding a squared macro-
nutrient intake in addition to macronutrient intake in
Model 2. These were tested in the same groups as the main
analyses (i.e., in the total cohort, or in subgroups, if inter-
actions were observed).
In case of violation of the assumption of normality, a
bootstrap method was used. Equality of variances were
tested by Levene’s test. Statistical software Stata, version
13.1 (Stata Corporation, College Station, TX, USA) was
used in all analyses.
Results
Maternal characteristics
Maternal background characteristics are shown in Table 1.
The mean (SD) maternal age was 33 (4) years and the
mean prepregnancy BMI was 31 (6) kg/m2. Almost half of
the mothers (n= 141; 47%) had GDM during the index
pregnancy. The mean (SD) age of the offspring at follow-
up was 5.0 years (0.5) and 138 (46%) were girls. The
mean (SD) BF% of girls was 19 (6) and that of boys 15
(6). The mean (SD) ISO-BMI for both the girls and boys
was 23 (4). Table 2 displays the mean maternal macro-
nutrient intakes and time spent on LTPA during preg-
nancy, separately in the first half of pregnancy and third
trimester, and combined to reflect total exposure across
pregnancy.
Maternal macronutrient intake and offspring
relative birthweight
None of the maternal macronutrient intakes were associated
with offspring’s relative birthweight (Supplementary Table 2).
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Maternal macronutrient intake and offspring ISO-
BMI and waist-to-height ratio (WHtR)
GDM, BMI, or breastfeeding did not modify any asso-
ciations between macronutrients and ISO-BMI and WHtR
(all p for interaction >0.05). Higher third trimester satu-
rated fatty acid (SFA) intake was associated with higher
ISO-BMI (Model 2), but the first half of pregnancy intake
or combined intake across pregnancy were not (Table 3).
No associations between maternal macronutrient intakes
(in the first half of pregnancy, third trimester, or com-
bined) and WHtR were detected.
Maternal macronutrient intake and offspring BFM
and BF%
GDM status modified the association between first half of
pregnancy n-3 PUFA intake and offspring BFM (p for
interaction <0.001) and BF% (p for interaction= 0.001) at
5 years of age. In women with normal glucose metabolism
during the index pregnancy, higher first half of pregnancy
intake of n-3 PUFA was associated with lower offspring
BFM and BF% at 5 years of age (Table 4). In women with
GDM, however, higher first half of pregnancy intake of n-3
PUFA was associated with higher offspring BFM and BF%
at 5 years of age. There were no differences in first half of
pregnancy n-3 PUFA intakes between women with normal
glucose tolerance and women with GDM (1.75 (0.39) vs.
1.8 (0.40), p= 0.70).
The association between maternal first half of pregnancy
n-3 PUFA intake and offspring BF% pointed toward the
Table 1 Maternal and offspring characteristics and offspring
anthropometric indicators at 5 years of age in mother–child dyads
with maternal 3-day food records completed in both first half of
pregnancy (5–18 weeks’ gestation) and third trimester, and in those




















Age, year, mean (SD) 32.9 (4.4) 0 33.0 (4.5) 0
BMI at 1st half of
pregnancy, kg/m2,
mean (SD)




14.7 (2.0) 0 14.6 (2.0) 1
Current smokers (in
1st trimester), n (%)








34.9 (1.1) 2 34.9 (1.2) 4
Gestational diabetes,
n (%)




39.9 (1.4) 0 39.9 (1.5) 0
Breastfeeding,
months, mean (SD)
4.2 (2.9) 17 4.2 (2.9) 21
Child
Boys, n (%) 122 (53) 0 163 (54) 0




3632 (494) 0 3664 (503) 0
z-birthweight,
mean (SD)
0.1 (0.9) 0 0.2 (1.0) 0
At 5-year follow-up
Age, year, mean (SD) 5.0 (0.5) 0 5.0 (0.5) 0
Waist
Boys 54.3 (3.5) 6 54.6 (3.9) 10
Girls 54.9 (5.0) 5 54.9 (4.9) 9
Waist–height ratio, mean (SD)
Boys 48.7 (2.6) 6 48.8 (2.9) 10
Girls 49.8 (3.9) 5 49.7 (3.9) 9
BMI, mean (SD)
Boys 16.0 (1.3) 0 16.1 (1.4) 0





















Boys 22.9 (3.6) 0 23.1 (4.0) 0
Girls 22.5 (4.1) 0 22.6 (4.0) 0
Fat mass, kg, mean (SD)
Boys 3.0 (1.3) 13 3.1 (1.5) 19
Girls 4.0 (2.0) 16 4.0 (4.0) 16
Fat as % from total bodyweight, mean (SD)
Boys 14.6 (5.4) 13 14.9 (5.6) 19
Girls 19.2 (6.1) 29 19.1 (6.1) 16
z-birthweight represents sex- and gestational age-adjusted birthweight
[22]. ISO-BMI represents age- and sex-standardized BMI converted to
adult scale [23].
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same direction with and without adjustment for LTPA, both
in women with normal glucose tolerance and in those with
GDM. However, this association was not significant in
those with GDM (Supplementary Table 1).
GDM did not modify the associations between third
trimester maternal n-3 PUFA intake and BFM or BF%, and,
in the total cohort, these associations were not statistically
significant (Table 4). GDM did not modify any other
associations between macronutrients and BFM and BF%.
Prepregnancy BMI and breastfeeding did not modify any
associations between macronutrients and BFM and BF%
(all p for interaction >0.05).
Both higher third trimester SFA intake and higher
combined SFA intake across pregnancy were associated
with higher offspring BFM and BF% (in Models 1 and 2,
Table 5).
Higher carbohydrate (CHO) intake across pregnancy was
associated with lower offspring BFM and borderline asso-
ciated with lower BF% (in Model 2). No other associations
between maternal macronutrient intakes and offspring BFM
and BF% were observed.
Sensitivity analyses
Because maternal n-3 PUFA, SFA, and CHO intakes during
pregnancy were associated with offspring ISO-BMI, BFM,
and BF%, we also examined the associations between
maternal n-3 PUFA, SFA, and CHO intakes at 12 months
and 5 years after delivery and offspring anthropometric
indicators. However, no associations with offspring ISO-
BMI, BFM, or BF% at 12 months or 5 years were detected
(Supplementary Table 3). No quadratic associations
between maternal macronutrient intakes and offspring BFM
or BF% were found.
Discussion
We found that GDM modified the associations between
maternal intake of n-3 PUFAs in the first half of pregnancy
and offspring BFM and BF% at 5 years of age. Maternal
intake of SFA during pregnancy was positively associated
with offspring ISO-BMI, BFM, and BF%. In contrast,
maternal CHO intake across pregnancy was negatively
associated with offspring BFM and BF%.
Only a few previous human studies have examined
associations between maternal macronutrient intakes during
pregnancy and offspring adiposity after infancy [8, 16–19].
Among the strengths of our study are the collection of
detailed maternal nutrient intake data at four timepoints,
during and after pregnancy, and the inclusion of data on the
offspring’s own nutrient intake. These enabled us to assess
the role of timing of maternal macronutrient intake during
pregnancy and the food environment of the offspring after
birth in the development of offspring adiposity. No asso-
ciations between maternal macronutrient intakes after
pregnancy and offspring anthropometric indictors were
found, and our analyses were adjusted for the child’s own
nutrient intake at 5 years. Hence, it is unlikely that our
findings result from confounding by maternal or child diet
composition after delivery.
Compared to the results of the present study, previous
cohort studies have reported both congruent [17, 18] and
discrepant [19] findings on the association of maternal n-3
Table 2 Maternal macronutrient
intakes and duration of leisure-
time physical activity per week
in first half of pregnancy, in the
third trimester of pregnancy, and










n Mean sd n Mean sd p n Mean sd
Nutrition 274 257 230
Energy intake, kcal/d 1900 420 1950 440 0.50 1930 380
Carbohydrates, E% 44.8 6.0 43.5 7.0 0.01 44.0 5.5
Sucrose, E% 8.5 3.8 8.5 4.5 0.31 8.4 3.3
Dietary fiber, g/1000 kcal 12.6 3.8 12.5 3.9 0.77 12.5 3.3
Total fat, E% 33.6 5.7 34.8 6.8 0.02 34.3 5.3
SFA, E% 12.3 2.9 12.8 3.5 0.10 12.6 2.7
MUFA, E% 11.6 2.3 11.9 2.6 0.04 11.8 2.0
n-3 PUFA, E% 1.8 0.4 1.8 0.5 0.50 1.8 0.3
n-6 PUFA, E% 4.5 1.1 4.7 1.4 0.03 4.6 1.0
Protein, E% 18.1 3.1 18.3 3.1 0.21 18.2 2.5
Duration of LTPA per week (min) 240 105 110 240 81 107 0.12 191 94 88
E% percentage of energy from total energy intake, SFA saturated fatty acids, MUFA monounsaturated fatty
acids, PUFA polyunsaturated fatty acids, LTPA leisure-time physical activity.
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PUFA intake during pregnancy and offspring adiposity.
Differences in the impact of maternal n-3 PUFA intakes in
healthy women vs. women with GDM in the first half of
pregnancy on offspring body composition could explain
some of these inconsistencies, as earlier studies have
examined average nutrient intakes across the entire
pregnancy. More recently, Brei et al. [8] showed that
higher late pregnancy n-3 PUFA intake is associated with
lower birthweight and newborn fat mass in the offspring,
although these associations did not persist until 1 year of
age. Donahue et al. (n= 1120), however, found an asso-
ciation between higher maternal n-3 PUFA intake and
lower sum of subscapular and tricep skinfold thicknesses
in children at 3 years of age [18], conforming to our
results in women without GDM. n-3 PUFAs block adi-
pose tissue development, leading to lower fat mass [24],
which could possibly contribute to the association of late
pregnancy maternal PUFA intake with reduced offspring
adiposity, although this finding did not reach significance
in our study. In a mouse model, increased maternal n-3
fatty acid intake (reduced n-6/n-3 PUFA ratio) was shown
to lead to lower body fat and traits indicative of an
obesity-resistant phenotype in the offspring [24]. How-
ever, although cohort studies have repeatedly found
inverse associations between maternal n-3 PUFA intake
during pregnancy and offspring adiposity [18, 25], these
have not been replicated in clinical trials testing n-3
PUFA supplementation in pregnant women [26].
Long-chain PUFAs are essential for normal fetal growth
and development. Since placental and fetal capacity to
synthesize them is low, the fetus depends on the maternal
supply of PUFAs [27]. Earlier studies have suggested
derangements in the placental transfer and/or feto-placental
metabolism of PUFAs in late pregnancy in women with
GDM or obesity [28–32], which could contribute to the lack
of benefit on offspring adiposity from increased late preg-
nancy n-3 PUFA intake in our study population. Similar
data on the first half of pregnancy is lacking and the flux of
lipids to the fetus is considerably lower at <20 weeks
gestation than at term [28]. However, GDM is characterized
by various maternal metabolic abnormalities (e.g., elevated
glucose and insulin) already in early pregnancy [33, 34],
and early changes in placental metabolism and growth in
response to disturbed maternal metabolism are increasingly
recognized as potential factors in the pathogenesis of fetal
adiposity [35–38]. Considering our observation of increased
offspring adiposity in women with GDM with high first half
of pregnancy n-3 PUFA intake, it is possible that placental
n-3 PUFA metabolism is altered in GDM already in the first
half of pregnancy.
Current evidence regarding the impact of maternal SFA
intake on offspring body composition is inconsistent. In a
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[17], maternal cumulative SFA intake during pregnancy
was not associated with offspring BMI or overweight at 2–7
years [17]. Likewise, Brei et al. (n= 208) [8] did not find
associations between SFA intake in early or late pregnancy
and offspring weight, BMI, BFM, or subcutaneous or
peritoneal fat area at birth or at the age of 1, 3, or 5 years.
The participants in these studies were leaner and the pro-
portion of mothers with GDM was null [17] or considerably
lower [8], compared to the mothers of the present study.
This may have contributed to the discrepancy in results,
especially considering the differences in maternal, placental,
and fetal lipid metabolism that characterize GDM/obese vs.
non-GDM/non-obese pregnancies [28, 39]. Murrin et al.
[16], on the other hand, discovered a positive association
between maternal SFA intake in the first trimester and
offspring weight at 5 years of age in 585 mother–child
dyads. This result, if weight is interpreted as an indication
of adiposity, is in line with our findings concerning third
trimester SFA intake and combined SFA intake across
gestation. It is possible that our smaller sample size may
have diluted the association between the first half of preg-
nancy intake and offspring anthropometric indicators.
Unfortunately, Murrin et al. did not report maternal back-
ground characteristics, such as BMI or GDM status, dis-
allowing detailed comparisons [16]. Data from animal
studies are consistent with our findings, since high maternal
SFA intake has been shown to result in increased neonatal
body mass [40], later adiposity [41], beta-cell loss and
glucose intolerance [42], as well as impaired appetite reg-
ulation [43], in the offspring.
In the present study, maternal SFA intake during late
pregnancy, as opposed to the first half of pregnancy, dis-
played a more pronounced association with offspring
anthropometric indicators. This is logical since the last tri-
mester of pregnancy is characterized by the most rapid fetal
growth and fat accretion, which is further promoted by
maternal obesity and/or diabetes which enhance the avail-
ability of lipids as a feto-placental fuel and trigger fetal
hyperinsulinemia [28]. Nearly half of our cohort was
composed of women with GDM, in whom maternal late
pregnancy free fatty acid, glycerol and triacylglycerol
concentrations have been shown to correlate with cord lipid
concentrations, newborn size, and adiposity [44, 45]. An
SFA-rich diet could also contribute to poorer maternal
glycemic control via worsening of late-pregnancy insulin
resistance [46], especially in our metabolically compro-
mised study population. It is also possible that excess SFA
could suppress the activity of specific enzymes (Δ5 and Δ6)
necessary for the synthesis of metabolically important long-
chain PUFAs in maternal and fetal tissues [47].
Brei et al. [8] found, in 186 mother–child dyads, that an
incremental increase in maternal fat and protein intake at the
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associated with lower offspring BFM up to 5 years. This is in
contrast to our study in which higher maternal CHO intake
was associated with lower offspring BFM and BF% at 5 years
of age. However, the average CHO intake was ~7 E% units
higher in the study population of Brei et al. as compared to
our study population, which could explain the discrepancy in
our results. The finding that only cumulative CHO intake
across pregnancy was associated with BFM and BF% prob-
ably attributes to the higher accuracy of measurement
achieved with 6 days rather than 3 days of food records.
We did not find an association between maternal mac-
ronutrient intake and newborn relative birthweight, in
agreement with some studies [41] but in contradiction to
others [48]. Our results may reflect the fact that birthweight
is not a measure of adiposity. It is possible that the children
with the highest BFM/BF% values already had higher
adiposity at birth [49], but it is also plausible that fetal
programming predisposed them to increased fat accumula-
tion after the neonatal period. The latter speculation is
supported by a meta-analysis of studies in rodents, which
concluded that maternal high-fat (mostly saturated) intake
did not affect offspring birthweight but increased weaning
weight, final bodyweight, and adiposity [41]. This is in
agreement with our results showing no association between
maternal SFA intake and offspring birthweight, but positive
associations between maternal SFA intake and offspring
BFM and BF% at 5 years of age. The possible cause–effect
relationships between maternal SFA intake and offspring
metabolism are myriad and remain to be elucidated, with
potential mechanisms ranging from adverse impacts of SFA
on feto-placental mitochondrial metabolism to alterations of
maternal/fetal gut microbiota [50–52].
A strength of our study is the availability of direct mea-
surement of offspring adiposity as BFM and BF%, instead of
relying only on bodyweight, BMI, or WHtR [53]. We were
able to adjust for a wide range of variables, in order to
minimize residual confounding. Since all the women who
participated in the present study were either obese or had a
history of GDM, and consequently their fetuses were
exposed to an altered intrauterine environment, the results
cannot be generalized to metabolically healthy pregnancies.
Our relatively small sample size is another limitation, which
may have attenuated some of the observed associations
between maternal macronutrient intakes and offspring
anthropometric indicators. Due to lack of data on newborn
BFM, BF%, or metabolic parameters (e.g., insulin or C-
peptide levels), we were not able to assess whether asso-
ciations between specific macronutrient intakes and off-
spring adiposity already existed in infancy. Similarly, due to
lack of data, we could not adjust for maternal macronutrient
intake during lactation as a possible confounder.
In metabolically burdened women, associations between
the first half of pregnancy n-3 PUFA intake and offspring
BFM and BF% at 5 years of age were modified by GDM. In
the first half of pregnancy, higher n-3 PUFA intake was
associated with lower offspring BFM and BF% in women
with normal glucose tolerance during pregnancy and higher
offspring BFM and BF% in women with GDM. Higher intake
of SFA during pregnancy was associated with higher ISO-
BMI, BFM, and BF% in the offspring at 5 years of age,
whereas higher intake of CHOs was associated with lower
offspring BFM and BF%. This study introduces novel evi-
dence of possible fetal programming by maternal macro-
nutrient intake in metabolically burdened women who
constitute a growing proportion of obstetric populations
worldwide. Taken together, our findings add to the accumu-
lating evidence on the role of maternal macronutrient intake in
offspring metabolic programming and suggest that its effects
may vary between normoglycemic women and women with
GDM and depend on the timing of feto-placental exposure.
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